Today's Reuters Health News Headlines - Yahoo! News:
|
|
Amgen, Astra to collaborate on several drugs
Mon,2 Apr 2012 11:28 PM PDT
Reuters -  (Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline. Under terms of the deal, Astra will make an upfront payment of $50 million to the world's largest biotechnology company, and the companies will share costs and profits on the drugs for a variety of autoimmune, inflammatory and respiratory diseases. ...
Full Story | Top |
GSK says new data support filing of diabetes drug
Mon,2 Apr 2012 11:14 PM PDT
Reuters - LONDON (Reuters) - GlaxoSmithKline plans to push ahead with plans to file its experimental once-weekly diabetes drug albiglutide for regulatory approval, following the read-out from a series of clinical trials. Albiglutide belongs to the same class of injectable GLP-1 medicines as Novo Nordisk's Victoza and Byetta, from Amylin Pharmaceuticals and Eli Lilly. Byetta was the first drug of the type. Last November, GSK reported that albiglutide cut blood sugar less than daily Victoza in the first of a series of late-stage clinical trials, dimming its prospects in an increasingly competitive market. ... Full Story | Top |
Feds raid "Princeton of Pot" in California
Mon,2 Apr 2012 08:47 PM PDT
Reuters -  OAKLAND, California (Reuters) - Federal agents, pressing a government clampdown on medical marijuana, raided a San Francisco Bay-area college known as the "Princeton of Pot" on Monday and briefly detained its founder. The sweep turned Oaksterdam University, which offers courses in the growing and dispensing of marijuana, into the latest flashpoint between federal law enforcement and medical cannabis advocates in California and other states where cannabis has been decriminalized for medicinal purposes. ...
Full Story | Top |
Tokyo chefs swell with anger over new blowfish laws
Mon,2 Apr 2012 08:41 PM PDT
Reuters -  TOKYO (Reuters) - With a scoop of a net Tokyo chef Naohito Hashimoto selects a poisonous blowfish, considered a delicacy in Japan, and with a few deft strokes of his gleaming knife starts the delicate process of preparing it for a customer. In moments, Hashimoto has separated the edible parts of the fish from organs filled with a poison more deadly than cyanide. For more than six decades, dicing blowfish in Tokyo has been the preserve of a small band of strictly regulated and licensed chefs, usually in exclusive restaurants. ...
Full Story | Top |
Death knell may sound for Canada's GMO pigs
Mon,2 Apr 2012 08:18 PM PDT
Reuters - WINNIPEG, Manitoba (Reuters) - Pigs that might have become the world's first genetically modified animals approved for human consumption may instead face an untimely end, as key backers of Canada's "Enviropig" project withdrew their support for the controversial engineered animal. Scientists at the University of Guelph, 90 km west of Toronto, bred the first GMO pig that was developed to address an environmental problem in 1999. ... Full Story | Top |
Obama to target Republicans over tax fairness
Mon,2 Apr 2012 04:27 PM PDT
Reuters -  WASHINGTON (Reuters) - President Barack Obama, seizing on Republican plans to slash spending that the White House sees as a potent vote winner for Democrats in this year's election, will use a speech on Tuesday to reinforce his message that his opponents favor the rich. In a week in which Republican Mitt Romney is expected to extend his lead in the race for his party's nomination to confront Obama in the November 6 election, the president will also speak at a conference on women in the economy, White House officials said. ...
Full Story | Top |
Obama takes a shot at Supreme Court over healthcare
Mon,2 Apr 2012 03:45 PM PDT
Reuters -  WASHINGTON (Reuters) - President Barack Obama took an opening shot at conservative justices on the Supreme Court on Monday, warning that a rejection of his sweeping healthcare law would be an act of "judicial activism" that Republicans say they abhor. Obama, a Democrat, had not commented publicly on the Supreme Court's deliberations since it heard arguments for and against the healthcare law last week. Known as the "Affordable Care Act" or "Obamacare," the measure to expand health insurance for millions of Americans is considered Obama's signature domestic policy achievement. ...
Full Story | Top |
Amgen, Astra to collaborate on several drugs
Mon,2 Apr 2012 03:43 PM PDT
Reuters - (Reuters) - Amgen Inc and British drugmaker AstraZeneca Plc announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline. Under terms of the deal, Astra will make an upfront payment of $50 million to the world's largest biotechnology company, and the companies will share costs and profits on the drugs for a variety of autoimmune, inflammatory and respiratory diseases. ...
Full Story | Top |
Feds raid "Princeton of Pot" in California
Mon,2 Apr 2012 02:34 PM PDT
Reuters - OAKLAND, California (Reuters) - Federal agents raided a cannabis cultivation college on Monday in the San Francisco Bay area widely known as the "Princeton of Pot" and the "Harvard of Hemp," authorities said, as the U.S. government pressed its clamp-down on medical marijuana. The sweep turned the college, which offers courses in the growing and dispensing of marijuana, into the latest flashpoint between federal law enforcement and medical cannabis advocates in California and other states where pot has been decriminalized for medicinal purposes. ...
Full Story | Top |
Romney eyes primary knockout, matchup with Obama looms
Mon,2 Apr 2012 02:22 PM PDT
Reuters -  GREEN BAY, Wisconsin., (Reuters) - As Mitt Romney sought to land a knockout blow against Rick Santorum in the race for the Republican U.S. presidential nomination, the difficulty of a general election matchup against Democratic President Barack Obama became clearer. Romney looked poised for victories in contests in Wisconsin, Maryland and Washington, D.C. on Tuesday, a sweep that would add pressure on conservative rival Santorum to yield to rising calls from party leaders for Republicans to rally behind Romney. ...
Full Story | Top |
Breast cancer screening tied to overdiagnosis
Mon,2 Apr 2012 02:12 PM PDT
Reuters - NEW YORK (Reuters Health) - A new report suggests that when a breast cancer screening program was rolled out in Norway, up to 10 women were diagnosed and treated for cancer unnecessarily for every breast cancer death that was prevented. That's because when doctors screen for cancer in women who don't have symptoms, it's impossible for them to tell whether a tumor picked up by mammography will grow quickly into advanced cancer or will only progress slowly or not at all, said lead author Dr. Mette Kalager. ... Full Story | Top |
Most alcohol, drug abuse starts in the teens: study
Mon,2 Apr 2012 02:08 PM PDT
Reuters - NEW YORK (Reuters Health) - A new survey of U.S. teenagers finds that most have used alcohol and drugs by the time they reach adulthood, and researchers say that could be setting up many of them for a lifetime of substance abuse. The new research, published in the Archives of General Psychiatry, found that almost four out of five teens had tried alcohol and more than 15 percent were abusing it by the time they turned 18 years old. Some 16 percent were abusing drugs by age 18. ... Full Story | Top |
Many little kids lack outdoor time with parents
Mon,2 Apr 2012 02:05 PM PDT
Reuters - NEW YORK (Reuters Health) - Half of preschoolers don't spend time playing outside with a parent each day, according to results from a recent survey. In interviews with parents of close to 9,000 kids, less than half of moms and only a quarter of dads reported taking their child for a walk or playing with them in the yard or park at least once a day. "It does make sense that for many parents, especially for parents who work outside the home... it's not so easy to have outdoor playtime with your children every day," said Dr. ... Full Story | Top |
Bird flu studies OK to publish: U.S. biosecurity expert
Mon,2 Apr 2012 01:05 PM PDT
Reuters - LONDON/NEW YORK (Reuters) - A U.S. biosecurity panel's recommendation that two controversial papers on bird flu be published in full is not a reversal of the stand it took last year out of concerns over terrorism, the head of the group said on Monday in London. "We had new information, confidential information, about benefits of this research, and we also had confidential information about the risks involved," said Paul Keim of Northern Arizona University, who is the acting chairman of the panel. "And the balance began to change. ... Full Story | Top |
Illumina board rejects sweetened Roche offer
Mon,2 Apr 2012 12:31 PM PDT
Reuters - (Reuters) - Illumina Inc said on Monday that its board unanimously rejected Roche Holding's increased offer to buy the genetic sequencing company for $51 per share, or about $6.7 billion, saying it dramatically undervalued the company. Illumina management told its shareholders that accepting the revised offer was not in their best interests and urged them not to tender any shares. The Swiss drugmaker last week raised its offer to buy Illumina from an initial overture of $44.50 per share in an effort to curry support from shareholders of the U.S. ... Full Story | Top |
| |
|
No comments:
Post a Comment